Avantor, Inc. (NYSE:AVTR – Free Report) – Stock analysts at Zacks Research cut their Q3 2026 earnings per share (EPS) estimates for shares of Avantor in a report released on Tuesday, March 25th. Zacks Research analyst D. Dey now expects that the company will post earnings per share of $0.27 for the quarter, down from their prior forecast of $0.29. The consensus estimate for Avantor’s current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor’s FY2026 earnings at $1.13 EPS and FY2027 earnings at $1.33 EPS.
Avantor (NYSE:AVTR – Get Free Report) last released its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the prior year, the firm posted $0.22 EPS.
Check Out Our Latest Analysis on AVTR
Avantor Stock Performance
Shares of AVTR opened at $16.19 on Thursday. The stock has a 50-day moving average of $18.40 and a two-hundred day moving average of $21.42. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. The stock has a market cap of $11.03 billion, a P/E ratio of 15.57, a P/E/G ratio of 1.55 and a beta of 1.30. Avantor has a one year low of $15.37 and a one year high of $28.00.
Institutional Investors Weigh In On Avantor
Several large investors have recently bought and sold shares of AVTR. Dodge & Cox boosted its holdings in shares of Avantor by 44.9% in the 4th quarter. Dodge & Cox now owns 99,145,770 shares of the company’s stock valued at $2,089,001,000 after buying an additional 30,727,673 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Avantor by 1.9% in the fourth quarter. Vanguard Group Inc. now owns 63,969,754 shares of the company’s stock valued at $1,347,843,000 after acquiring an additional 1,211,418 shares during the period. Barrow Hanley Mewhinney & Strauss LLC raised its position in Avantor by 41.4% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 30,528,092 shares of the company’s stock valued at $643,227,000 after purchasing an additional 8,936,879 shares during the last quarter. State Street Corp increased its stake in Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after purchasing an additional 8,206,695 shares during the period. Finally, Canada Pension Plan Investment Board grew its holdings in shares of Avantor by 0.5% during the fourth quarter. Canada Pension Plan Investment Board now owns 21,037,089 shares of the company’s stock worth $443,251,000 after buying an additional 112,644 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Insider Transactions at Avantor
In other Avantor news, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares of the company’s stock, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- What Are Dividend Challengers?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- What is the Euro STOXX 50 Index?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.